BTEC to host NC State/Seqirus technical symposium Dec. 7

BTEC will host the third NC State/Seqirus Technical Symposium from 1:00–5:00 p.m. Monday, Dec. 7, 2015, in room 135. Seqirus (Sek-eer-us) is the new name for Novartis influenza vaccines under the global biotherapeutics leader CSL.

The program is as follows:

Title Presenter

Basic discoveries about formation of T cell memory to influenza explain weaknesses in current vaccine approaches and suggest potential improvements

Susan Swain, Ph.D., Professor of Immunology, University of Massachusetts Medical School

A WHO-BARDA-BTEC partnership for hands-on training in influenza vaccine manufacture

Jennifer Pancorbo, Ph.D., Assistant Director, Bioprocess Services, BTEC

Acetalated dextran: a spoonful of sugar helps the medicine (and vaccines) go down

Kristy Ainslie, Ph.D., Division of Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina – Chapel Hill

History of emulsion based adjuvants and their use in influenza vaccination

Manmohan Singh, Head of Global Technology Development, Seqirus

Interested individuals are invited to attend. No pre-registration is necessary.